Genscript Biotech Corp (1548) fair value: what the stock is really worth
As of Nov 13, 2026: fair value (intrinsic value) of Genscript Biotech Corp stock HK$22.06, price HK$30.38, that is 27.4% below the price, quality 55 out of 100. Rating: overvalued. Calculated from audited financials with 13 of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Genscript Biotech Corp
1548 · HKExpensive (fair value 27% below the price), but solid company and rising price: meets 2 of 3 rules.
Main risks:
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 14, 2026.
How to read this chart
60‑month range HK$8.23 – HK$49.14 · fair‑value band HK$13.22 – HK$41.48 · the HK$30.38 price screens above the HK$22.06 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 14, 2026.
Every Wednesday you see whether Genscript Biotech is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.
Show moreShow less
It operates through Life Science Services and Products; Biologics Development Services; and Industrial Synthetic Biology Products segments. The Life Science Services and Products segment provide research services and products which are used in fundamental to life-science research and application.
The Biologics Development Services segment which helps biopharmaceutical and biotech companies accelerate the development of therapeutic antibodies, and gene/cell therapy products with an integrated platform.
The Industrial Synthetic Biology Products segment develops and produces industrial enzymes through non-pathogenic microbial strains constructed using genetic engineering.
It also offers SurePAGE, a precast gel series; CytoSinct, a Nanobeads product and services; and Benz-Neburase, a genetically engineered endonuclease.
In addition, the company provides automated protein and antibody purification system; automated maxi-plasmid purification; automated mini-scale purification for plasmid, protein, and antibody; eBlot and eStain, a protein transfer and staining system; eZwest Lite, an automated western blotting device; CytoSinct, a cell isolation solution; pharmacokinetics and immunogenicity ELISA kits; COVID-19 detection cPass technology kits; and GenBox, a mini electrophoresis tank.
It serves antibody drug discovery; gene therapy; vaccine; in vitro diagnostics; gene editing; plant biology; and synthetic biology solutions. The company was founded in 2002 and is headquartered in Wan Chai, Hong Kong.
Stock analysis
Genscript Biotech Corp (1548) currently trades at HK$30.38, while our model-based Fair Value estimate is HK$22.06, 27% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of HK$22.06 per share, and 0 of the 13 models we run sit above the HK$30.38 price.
Bear case: the Earnings-Based group reads lowest at HK$7.39, and 13 of the 13 models stay below the price. Data coverage for this calculation is medium.
Scenario range: HK$13.22 (bear) to HK$41.48 (bull), the price of HK$30.38 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 55/100 (solid quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Genscript Biotech Corp reported revenue of $960M in FY2025 versus $511M in FY2021, a compound +17.1%/yr. Reported net income was −$533M in FY2025.
Key figures
Market cap HK$69.3B (≈ $8.8B) Mid · P/E ex one-offs 36.8 · P/S ratio 85.3 · Net margin −55.5% · Return on equity −15.3% · Return on assets (EBIT) −6.6% (5-year average) · Operating margin 12.3% · Revenue (TTM) $845M.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 21 out of 100 (low confidence).
What moves the price
The share trades about 38% below its 52-week high and 187% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −5% fair-value upside, at −27%, 1548 screens richer than that median.
Fair Value models
All 13 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Growth Forecast
Earlier news
- Genscript Biotech (SEHK:1548) Stock Looks Stretched On Its 160% YTD Run
- GenScript Launches Life Sciences Startup PitchFest with NVIDIA to Accelerate Biotech Innovation
- DNA Synthesis Market Outlook 2026-2035 - Featuring Profiles of Leading Companies Integrated DNA Technologies, GenScript Biotech, and Twist B
Compare Genscript Biotech Corp with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Biotechnology · 850 stocks
Valuation Multiplesvs Biotechnology median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Fair value gap by industry
- Return on assets by industry
- Piotroski F-Score screener with fair value
- Undervalued stocks: Hong Kong Stocks
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Biotechnology stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Regeneron Pharmaceuticals, Inc REGN | $955.47 | $1,275 | +33% | vs 1548 |
| Vertex Pharmaceuticals Incorporated VRTX | $538.60 | $592.46 | +10% | vs 1548 |
| Samsung Biologics Co 207940 | 1,411,000 KRW | 1,552,100 KRW | +10% | vs 1548 |
| Genmab A/S GMAB | kr 3,448 | kr 3,793 | +10% | vs 1548 |
| argenx SE ARGX | $960.04 | $908.40 | −5% | vs 1548 |
| CSL Limited CSL | A$202.52 | A$185.51 | −8% | vs 1548 |
| Moderna, Inc MRNA | $223.37 | $139.99 | −37% | vs 1548 |
| Revolution Medicines, Inc RVMD | $172.29 | $88.78 | −48% | vs 1548 |
| Celltrion, Inc 068270 | 214,000 KRW | 74,945 KRW | −65% | vs 1548 |
| Royalty Pharma plc RPRX | $69.31 | $19.01 | −73% | vs 1548 |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Genscript Biotech Corp (1548) overvalued or undervalued?
What is the fair value of 1548?
What is the quality score of 1548?
What is the price target for Genscript Biotech Corp (1548)?
What is the Genscript Biotech Corp stock forecast for 2026?
What is the revenue of Genscript Biotech Corp (1548)?
What growth is priced into Genscript Biotech Corp (1548)?
What discount rate (WACC) does the fair value of 1548 use?
What is a reverse DCF?
How much growth has Genscript Biotech Corp (1548) delivered so far?
How fast is the sector of Genscript Biotech Corp (1548) growing?
What is the free cash flow yield of Genscript Biotech Corp (1548)?
What is the intrinsic value of Genscript Biotech Corp (1548)?
Is Genscript Biotech Corp stock overvalued or undervalued in 2026?
Is fair value the same as the market price of 1548?
How much is Genscript Biotech Corp worth?
What do the bullish and bearish scenarios say about 1548?
How solid is the balance sheet of Genscript Biotech Corp (1548)?
How far is 1548 from its 52-week high?
Which stocks are comparable to Genscript Biotech Corp?
Is Genscript Biotech Corp stock attractive at the current price?
How is the fair value of 1548 calculated?
Is it still worth investing in stocks now?
What is the share price of Genscript Biotech Corp (1548)?
What should I pay attention to with Genscript Biotech Corp right now?
Key figures of Genscript Biotech Corp
How large is the market capitalisation of Genscript Biotech Corp (1548)?
What is the P/E ratio of Genscript Biotech Corp (1548) excluding one-off items?
What is the P/S ratio of Genscript Biotech Corp (1548)?
What is the net margin of Genscript Biotech Corp (1548)?
What is the return on equity of Genscript Biotech Corp (1548)?
What is the EBIT return on assets of Genscript Biotech Corp (1548)?
What is the operating margin of Genscript Biotech Corp (1548)?
How fast is revenue growing at Genscript Biotech Corp (1548)?
How much net debt does Genscript Biotech Corp (1548) carry?
Watch Genscript Biotech Corp in the live analysis
One click puts Genscript Biotech Corp on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.